The Board of Directors of Viatris declared the first quarterly cash dividend of $0.11 per share on the Company’s issued and outstanding common stock on May 7, 2021. The cash dividend will be paid on June 16, 2021 to stockholders who were on the books on May 24, 2021 at the close of business. The Board of Directors will decide whether to declare and pay future dividends to common stockholders based on a variety of factors, including the Company’s financial condition, earnings, capital requirements of its businesses, legal requirements, regulatory constraints, industry practice, and other factors that the Board of Directors deems relevant.
What will Viatris dividend be?
On August 23, 2021, (VTRS) will begin trading ex-dividend. On September 16, 2021, the company will issue a cash dividend of $0.11 per share. The cash dividend is payable to shareholders who acquired VTRS before the ex-dividend date. The dividend yield is 2.99 percent at the current stock price of $14.73.
Is Viatris a good investment?
While Viatris may prove to be a dependable and generally safe investment in the coming years, it may not be the ideal option for accumulating wealth. While it may have a place in your retirement portfolio if you prefer dividend-paying companies, you’d have to put in a considerable amount of money up front to earn a big quantity of cash flow in return.
So, while Viatris may assist you in becoming a millionaire, it is unlikely to be the primary contributor to your success. Given its weak performance since the merger, an automatically diversified index fund would be a better option. On the other hand, because this stock is going to be a slow burn, waiting a few more quarters to see how its financials are progressing before making a purchase decision isn’t a big deal.
Does Tesla pay dividends 2021?
Tesla’s common stock has never paid a dividend. We want to keep all future earnings to fund future expansion, so no cash dividends are expected in the near future.
Do Pfizer pay dividends?
BUSINESS WIRENEW YORK(BUSINESS WIRE) Pfizer Inc. (NYSE: PFE) stated today that its board of directors has authorized a 39-cent fourth-quarter 2021 dividend on the company’s common stock, which will be paid on December 6, 2021 to stockholders of record on November 5, 2021. Pfizer will pay its 332nd consecutive quarterly cash dividend in the fourth quarter of 2021.
Why did I get shares of Viatris?
Because Viatris was founded by the combination of Mylan with Upjohn, Pfizer’s generics division (NYSE:PFE). For every 100 shares of Pfizer held, Viatris owners received a little more than 12 shares of Viatris. Shareholders of Mylan received a Viatris share for each Mylan share they previously owned.
Is Viatris a buy or sell?
The consensus rating for Viatris is Hold. The average rating score for the company is 2.25, with three buy ratings, nine hold ratings, and 0 sell ratings.
What does the company Viatris do?
With over 1,400 authorized medicinal compounds in its portfolio, the company produces and sells a wide range of pharmaceuticals. It owns brands (such as Viagra, Xanax, and Lipitor), generics (including branded and complicated generics), biosimilars, OTC medications, and active pharmaceutical ingredients (APIs). Cardiovascular, infectious illness, oncology, immunology, CNS and anesthesia, women’s healthcare, diabetes and metabolism, gastrointestinal, respiratory and allergy, and dermatology are among the therapeutic areas covered by Viatris medicines.
Since Viatris’ founding, the following products have been launched or acquired regulatory approval:
- In April 2021, the European Commission approved Abevmy (Bevacizumab), a biosimilar.
- In February 2021, Hulio (Adalimumab), a biosimilar, was launched in Japan and Canada.
- In February 2021, the European Commission approved Kixelle (Insulin aspart), a biosimilar.
- Dolutegravir was approved by the US Food and Drug Administration in December 2020 to treat HIV/AIDS in children in low- and middle-income countries. The strawberry-flavored version was made available at a 75 percent reduction over earlier treatments to make it easier to give to youngsters.
- In July 2021, the US FDA approved Semglee (Insulin glargine-yfgn) as the first interchangeable biosimilar. The approval permits pharmacists to use Semglee instead of Lantus as a reference product. The interchangeable biosimilars were launched in November 2021 in both branded and unbranded variants.
Does Johnson and Johnson pay dividends?
4 January 2021, New Brunswick, NJ Johnson & Johnson today announced that its Board of Directors has authorized a cash dividend of $1.01 per share on the company’s common stock for the first quarter of 2021. The dividend will be paid on March 9, 2021, to stockholders who were on the books on February 23, 2021. The stock will go ex-dividend on February 22, 2021.
We believe that excellent health is the cornerstone of lively lives, healthy communities, and forward development at Johnson & Johnson. That’s why, for over 130 years, we’ve worked to keep people healthy at all ages and stages of life. We are determined to utilize our reach and size for good as the world’s largest and most broadly based health care corporation today. We work to increase accessibility and affordability, build healthier communities, and make a healthy mind, body, and environment accessible to everyone, everywhere. We’re combining our hearts, science, and ingenuity to dramatically alter humanity’s health trajectory.
What is Coca Cola dividend?
For than a century, Coca-Cola has been quenching people’s thirst. The company manufactures and sells its beverages all around the world, with a focus on restaurants, movie theaters, and theme parks. The technique backfired during the coronavirus outbreak, but it’s now paying off as economies recover.
Coca-Cola pays a quarterly dividend of $0.42 per share, resulting in a dividend yield of 3.07 percent. The company’s dividend payout ratio, or the percentage of earnings paid out as dividends, has risen to over 100% in recent years. In particular, a dividend payout ratio of more than 100% is unsustainable in the long run since the company will eventually run out of cash.
Is Viatris a spinoff?
Viatris was formed as a result of Pfizer Inc.’s (“Pfizer”) spin-off of its global, largely off-patent branded and generic established medicines business (the “Upjohn Business”) and the subsequent merger of the Upjohn Business with Mylan N.V. (“Mylan”).
